Improving opioid effectiveness: from ideas to evidence (Q36057741)

11 August 2017

1 reference

title

Improving opioid effectiveness: from ideas to evidence (English)

1 reference

11 August 2017

Eija Kalso

1

0 references

publication date

1 April 2005

1 reference

11 August 2017

published in

European Journal of Pain

1 reference

11 August 2017

volume

9

1 reference

11 August 2017

issue

2

1 reference

11 August 2017

page(s)

131-135

1 reference

Effect of gabapentin-like compounds on development and maintenance of morphine-induced conditioned place preference

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.05.007

Ketamine as adjuvant to opioids for cancer pain. A qualitative systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.05.007

The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.05.007

Synergy between mu opioid ligands: evidence for functional interactions among mu opioid receptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.05.007

Addition of ultralow dose naloxone to postoperative morphine PCA: unchanged analgesia and opioid requirement but decreased incidence of opioid side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.05.007

Opioid and anti-opioid peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.05.007

The combination of NMDA antagonism and morphine produces profound antinociception in the rat dorsal horn

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.05.007

A randomized study of the effects of single-dose gabapentin versus placebo on postoperative pain and morphine consumption after mastectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.05.007

Epidural clonidine analgesia for intractable cancer pain. The Epidural Clonidine Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.05.007

Opioid-sparing effects of a low-dose infusion of naloxone in patient-administered morphine sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.05.007

Gabapentin Blocks and Reverses Antinociceptive Morphine Tolerance in the Rat Paw-pressure and Tail-flick Tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.05.007

Regulation of opioid receptor trafficking and morphine tolerance by receptor oligomerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.05.007

Analgesic effects of dextromethorphan and morphine in patients with chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.05.007

Epidural and subcutaneous morphine in the management of cancer pain: a double-blind cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.05.007

MorphiDex (MS:DM) double-blind, multiple-dose studies in chronic pain patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.05.007

RP 67580, a selective antagonist of neurokinin-1 receptors, modifies some of the naloxone-precipitated morphine withdrawal signs in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.05.007

A combination of gabapentin and morphine mediates enhanced inhibitory effects on dorsal horn neuronal responses in a rat model of neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.05.007

Oral naloxone reverses opioid-associated constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.05.007

Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.05.007

IV diclofenac in post-thoracotomy pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.05.007

Comparative effects of cyclo-oxygenase and nitric oxide synthase inhibition on the development and reversal of spinal opioid tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.05.007

Inhibition of neurokinin-1-substance P receptor and prostanoid activity prevents and reverses the development of morphine tolerance in vivo and the morphine-induced increase in CGRP expression in cultured dorsal root ganglion neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.05.007

Evidence for the involvement of the mu but not delta opioid receptor subtype in the synergistic interaction between opioid and alpha 2 adrenergic antinociception in the rat spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.05.007

The role of spinal neuropeptides and prostaglandins in opioid physical dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.05.007

Inhibition of Morphine Tolerance and Dependence by the NMDA Receptor Antagonist MK-801

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.05.007

Dextromethorphan attenuates morphine withdrawal syndrome in neonatal rats passively exposed to morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.05.007

The clinically available NMDA receptor antagonist dextromethorphan attenuates acute morphine withdrawal in the neonatal rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.05.007

10.1016/J.EJPAIN.2004.05.007

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference